MAXHEALTH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | MAXHEALTH | Market Cap | 96,643 Cr. | Current Price | 993 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 137 | Book Value | 87.3 ₹ | Dividend Yield | 0.15 % | ROCE | 12.5 % |
| ROE | 9.45 % | Face Value | 10.0 ₹ | DMA 50 | 1,003 ₹ | DMA 200 | 1,062 ₹ |
| Chg in FII Hold | -5.16 % | Chg in DII Hold | 5.12 % | PAT Qtr | 200 Cr. | PAT Prev Qtr | 160 Cr. |
| RSI | 49.6 | MACD | 3.48 | Volume | 24,37,699 | Avg Vol 1Wk | 16,29,336 |
| Low price | 903 ₹ | High price | 1,314 ₹ | PEG Ratio | 4.35 | Debt to equity | 0.08 |
| 52w Index | 21.9 % | Qtr Profit Var | 5.45 % | EPS | 7.10 ₹ | Industry PE | 47.1 |
📈 Optimal Buy Price
Entry zone: ₹985–₹1,000, near DMA 50 support. Avoid chasing above ₹1,010 unless volume expands beyond weekly average.
🎯 Exit Levels
- Profit-taking: ₹1,025–₹1,040 if momentum sustains
- Stop-loss: Below ₹970 (weakness under support)
⏳ Intraday Exit Guidance
If already holding, consider exiting if RSI dips below 48, price fails to hold above ₹985, or intraday volume momentum fades below 20 lakh with stagnant price action. Book profits near ₹1,025–₹1,040 if momentum slows.
✅ Positive
Quarterly PAT growth (₹160 Cr. → ₹200 Cr.), EPS at ₹7.10 shows earnings stability, DII inflows (+5.12%) support sentiment, debt-to-equity at 0.08 reflects low leverage, and price trading above 52-week low zone offers recovery potential.
⚠️ Limitation
Extremely high valuation (P/E 137 vs industry 47.1), weak ROE (9.45%) and ROCE (12.5%), PEG ratio at 4.35 indicates overvaluation relative to growth, and RSI at 49.6 reflects neutral momentum.
📉 Company Negative News
FII holdings decreased (-5.16%), valuation multiples remain stretched despite earnings growth, and momentum indicators show limited upside strength.
📊 Company Positive News
Sequential profit growth of 5.45%, strong domestic institutional support, and MACD positive at 3.48 confirming mild bullish bias.
🏥 Industry
Healthcare sector average P/E at 47.1, Max Healthcare trades at a steep premium (137). Sector outlook supported by rising demand for healthcare services and hospital expansion.
🔎 Conclusion
Max Healthcare is a cautious intraday candidate with strong institutional support but stretched valuations. Best suited for disciplined trades near ₹985–₹1,000 with exits around ₹1,025–₹1,040. Maintain strict stop-loss below ₹970 and monitor RSI/volume closely for intraday signals.